Revvity, Inc. Files 10-Q for Q1 2024
Ticker: RVTY · Form: 10-Q · Filed: May 7, 2024 · CIK: 31791
Sentiment: neutral
Topics: Revvity, 10-Q, Financial Report, Q1 2024, SEC Filing
TL;DR
<b>Revvity, Inc. has filed its Q1 2024 10-Q report, detailing its financial performance and corporate information.</b>
AI Summary
REVVITY, INC. (RVTY) filed a Quarterly Report (10-Q) with the SEC on May 7, 2024. Revvity, Inc. reported financial results for the period ending March 31, 2024. The company's fiscal year ends on December 29th. Revvity, Inc. is incorporated in Massachusetts (MA). The company's principal executive offices are located at 940 Winter Street, Waltham, MA. The filing is a 10-Q, indicating a quarterly report.
Why It Matters
For investors and stakeholders tracking REVVITY, INC., this filing contains several important signals. This 10-Q filing provides crucial insights into Revvity's financial health and operational performance during the first quarter of 2024, which is essential for investors to assess the company's current standing and future prospects. Understanding the details within this report allows stakeholders to evaluate Revvity's strategic direction, market position, and adherence to financial reporting standards.
Risk Assessment
Risk Level: low — REVVITY, INC. shows low risk based on this filing. The filing is a standard 10-Q, providing routine financial disclosures without immediate red flags, indicating a low level of risk associated with this specific filing.
Analyst Insight
Review the detailed financial statements and management's discussion and analysis within the 10-Q to understand Revvity's Q1 2024 performance and outlook.
Key Numbers
- 2024-03-31 — Period of Report (Conformed Period of Report)
- 2024-05-07 — Filed As Of Date (Filed As Of Date)
- 12/29 — Fiscal Year End (Fiscal Year End)
- 042052042 — IRS Number (IRS Number)
Key Players & Entities
- REVVITY, INC. (company) — Filer name
- 0000031791 (company) — Central Index Key
- MA (location) — State of Incorporation and Business Address
- Waltham (location) — Business Address City
- PERKINELMER INC (company) — Former Company Name
- EG&G INC (company) — Former Company Name
- EDGERTON GERMESHAUSEN & GRIER INC (company) — Former Company Name
- 3826 (industry) — Standard Industrial Classification
FAQ
When did REVVITY, INC. file this 10-Q?
REVVITY, INC. filed this Quarterly Report (10-Q) with the SEC on May 7, 2024.
What is a 10-Q filing?
A 10-Q is a quarterly financial report with unaudited financials, management discussion, and interim business updates. This particular 10-Q was filed by REVVITY, INC. (RVTY).
Where can I read the original 10-Q filing from REVVITY, INC.?
You can access the original filing directly on the SEC's EDGAR system. The filing is publicly available and includes all exhibits and attachments submitted by REVVITY, INC..
What are the key takeaways from REVVITY, INC.'s 10-Q?
REVVITY, INC. filed this 10-Q on May 7, 2024. Key takeaways: Revvity, Inc. reported financial results for the period ending March 31, 2024.. The company's fiscal year ends on December 29th.. Revvity, Inc. is incorporated in Massachusetts (MA)..
Is REVVITY, INC. a risky investment based on this filing?
Based on this 10-Q, REVVITY, INC. presents a relatively low-risk profile. The filing is a standard 10-Q, providing routine financial disclosures without immediate red flags, indicating a low level of risk associated with this specific filing.
What should investors do after reading REVVITY, INC.'s 10-Q?
Review the detailed financial statements and management's discussion and analysis within the 10-Q to understand Revvity's Q1 2024 performance and outlook. The overall sentiment from this filing is neutral.
How does REVVITY, INC. compare to its industry peers?
Revvity, Inc. operates within the Laboratory Analytical Instruments industry (SIC 3826). This sector involves the manufacturing and distribution of scientific and technical instruments used for analysis and measurement.
Are there regulatory concerns for REVVITY, INC.?
As a publicly traded company, Revvity, Inc. is subject to the reporting requirements of the Securities and Exchange Commission (SEC), including the filing of quarterly reports (10-Q) under the Securities Exchange Act of 1934.
Industry Context
Revvity, Inc. operates within the Laboratory Analytical Instruments industry (SIC 3826). This sector involves the manufacturing and distribution of scientific and technical instruments used for analysis and measurement.
Regulatory Implications
As a publicly traded company, Revvity, Inc. is subject to the reporting requirements of the Securities and Exchange Commission (SEC), including the filing of quarterly reports (10-Q) under the Securities Exchange Act of 1934.
What Investors Should Do
- Access and review the full 10-Q filing for detailed financial statements, including balance sheets, income statements, and cash flow statements.
- Analyze the Management's Discussion and Analysis (MD&A) section for qualitative insights into the company's performance, risks, and future outlook.
- Compare the Q1 2024 results with previous periods and industry benchmarks to assess performance trends.
Key Dates
- 2024-03-31: Quarter End — End of the reporting period for the 10-Q filing.
- 2024-05-07: Filing Date — Date the 10-Q was officially filed with the SEC.
Year-Over-Year Comparison
This is the initial 10-Q filing for Revvity, Inc. under its current name, following its transition from PerkinElmer Inc. Therefore, direct comparisons to prior periods under the 'Revvity' name are not applicable within this specific filing document itself, though historical data may be referenced.
Filing Stats: 4,527 words · 18 min read · ~15 pages · Grade level 17.3 · Accepted 2024-05-07 14:05:49
Key Financial Figures
- $1 — ange on which registered Common stock, $1 par value per share RVTY The New York S
Filing Documents
- pki-20240331.htm (10-Q) — 1028KB
- rvty-03312024xex_311.htm (EX-31.1) — 10KB
- rvty-03312024xex_312.htm (EX-31.2) — 10KB
- rvty-03312024xex_321.htm (EX-32.1) — 6KB
- 0000031791-24-000014.txt ( ) — 8867KB
- pki-20240331.xsd (EX-101.SCH) — 119KB
- pki-20240331_cal.xml (EX-101.CAL) — 84KB
- pki-20240331_def.xml (EX-101.DEF) — 748KB
- pki-20240331_lab.xml (EX-101.LAB) — 1273KB
- pki-20240331_pre.xml (EX-101.PRE) — 952KB
- pki-20240331_htm.xml (XML) — 756KB
FINANCIAL INFORMATION
PART I. FINANCIAL INFORMATION
Unaudited Financial Statements
Item 1. Unaudited Financial Statements 4 Condensed Consolidated Statements of Operations 4 Condensed Consolidated Statements of Comprehensive Income 5 Condensed Consolidated Balance Sheets 6 Condensed Consolidated Statements of Stockholders' Equity 7 Condensed Consolidated Statements of Cash Flows 8 Notes to Condensed Consolidated Financial Statements 10
Management's Discussion and Analysis of Financial Condition and Results of Operations
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 21 Overview 21 Critical Accounting Policies and Estimates 21 Consolidated Results of Continuing Operations 22 Reporting Segment Results of Continuing Operations 23 Discontinued Operations 24 Liquidity and Capital Resources 24 Dividends 26 Effects of Recently Adopted and Issued Accounting Pronouncements 27
Quantitative and Qualitative Disclosures About Market Risk
Item 3. Quantitative and Qualitative Disclosures About Market Risk 27
Controls and Procedures
Item 4. Controls and Procedures 27
OTHER INFORMATION
PART II. OTHER INFORMATION
Legal Proceedings
Item 1. Legal Proceedings 28
Risk Factors
Item 1A. Risk Factors 28
Unregistered Sales of Equity Securities and Use of Proceeds
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 36
Other Information
Item 5. Other Information 37
Exhibits
Item 6. Exhibits 37
Signatures
Signatures 39 3 Table of Contents
FINANCIAL INFORMATION
PART I. FINANCIAL INFORMATION
Unaudited Financial Statements
Item 1. Unaudited Financial Statements REVVITY, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) Three Months Ended March 31, 2024 April 2, 2023 (In thousands, except per share data) Product revenue $ 565,755 $ 592,280 Service revenue 84,165 82,585 Total revenue 649,920 674,865 Cost of product revenue 262,523 257,901 Cost of service revenue 32,350 35,598 Total cost of revenue 294,873 293,499 Selling, general and administrative expenses 260,571 248,557 Research and development expenses 50,360 56,690 Operating income from continuing operations 44,116 76,119 Interest and other expense, net 9,567 46,679 Income from continuing operations before income taxes 34,549 29,440 Provision for income taxes 5,853 4,595 Income from continuing operations 28,696 24,845 (Loss) income from discontinued operations ( 2,683 ) 544,630 Net income $ 26,013 $ 569,475 Basic earnings per share: Income from continuing operations $ 0.23 $ 0.20 (Loss) income from discontinued operations ( 0.02 ) 4.31 Net income $ 0.21 $ 4.51 Diluted earnings per share: Income from continuing operations $ 0.23 $ 0.20 (Loss) income from discontinued operations ( 0.02 ) 4.31 Net income $ 0.21 $ 4.50 Weighted average shares of common stock outstanding: Basic 123,428 126,285 Diluted 123,538 126,469 Cash dividends declared per common share $ 0.07 $ 0.07 The accompanying notes are an integral part of these condensed consolidated financial statements. 4 Table of Contents REVVITY, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME (Unaudited) Three Months Ended March 31, 2024 April 2, 2023 (In thousands) Net income $ 26,013 $ 569,475 Other comprehensive (loss) income: Foreign currency translation adjustments, net of income taxes: Amounts recognized in other comprehensive income ( 48,927 ) 52,008 Less: amounts reclassified to earnings — ( 90,814 ) Net foreign currency translation adjustments, net of i